Blevins R D, Halstenson C E, Salem N G, Matzke G R
Antimicrob Agents Chemother. 1984 May;25(5):603-6. doi: 10.1128/AAC.25.5.603.
The pharmacokinetics of vancomycin were studied in four patients on continuous ambulatory peritoneal dialysis. After a single intravenous infusion of 10 mg/kg of total body weight, multiple blood, urine, and dialysate samples were collected during a 72-h evaluation period. The steady-state volume of distribution was 0.73 +/- 0.07 (mean +/- standard deviation) liters/kg with a beta half-life of 90.2 +/- 24.2 h. The continuous ambulatory peritoneal dialysis clearance of vancomycin was 1.35 +/- 0.35 ml/min, and the serum clearance was 6.4 +/- 1.1 ml/min. Peritoneal dialysate concentrations of vancomycin were rapidly attained after the intravenous infusion and averaged 2.2 +/- 0.7 mg/liter throughout the 72-h observation period. A loading dose of 23 mg/kg followed by a maintenance dose of 17 mg/kg every 7 days should attain and maintain therapeutic serum and dialysate concentrations. More frequent dosing may be necessary for less susceptible organisms.
对4例持续性非卧床腹膜透析患者的万古霉素药代动力学进行了研究。在单次静脉输注10mg/kg总体重后,在72小时的评估期内采集了多个血液、尿液和透析液样本。稳态分布容积为0.73±0.07(均值±标准差)升/千克,β半衰期为90.2±24.2小时。万古霉素的持续性非卧床腹膜透析清除率为1.35±0.35毫升/分钟,血清清除率为6.4±1.1毫升/分钟。静脉输注后,腹膜透析液中万古霉素浓度迅速达到,在72小时观察期内平均为2.2±0.7毫克/升。负荷剂量23mg/kg,随后每7天维持剂量17mg/kg,应能达到并维持治疗性血清和透析液浓度。对于敏感性较低的微生物,可能需要更频繁给药。